2017
DOI: 10.5935/abc.20170113
|View full text |Cite
|
Sign up to set email alerts
|

Myocardial Edema without Fibrosis by Magnetic Resonance T2 Mapping in Acute Chagas' Myocarditis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…It is important to emphasize that Souza et al (2017) observed only myocardial edema, without myocardial fibrosis, through cardiac resonance, but in only one subject with acute Chagas disease [30].…”
Section: Discussionmentioning
confidence: 96%
“…It is important to emphasize that Souza et al (2017) observed only myocardial edema, without myocardial fibrosis, through cardiac resonance, but in only one subject with acute Chagas disease [30].…”
Section: Discussionmentioning
confidence: 96%
“…A case of Chagas myocarditis in an adult patient reported that this technique helped diagnose myocarditis in the acute phase and over the follow-up period, showing progressive regression of the edematous myocardial areas in serial CMR tests. 54 The use of myocardial mapping in the chronic phase of Chagas disease is promising, as it may reveal subclinical changes and identify individuals at high risk of progressing to more advanced CCDC stages.…”
Section: Myocarditis Assessment Of Chagas Patientsmentioning
confidence: 99%
“…Moreover, recent studies conducted in tertiary care centers have shown that late gadolinium enhancement analysis (LGE) can be used for optimal assessment of disease severity and can also act as a surrogate for prognosis in patients with overt Ch-CMP depending on the amount of scar found [113,[156][157][158][159][160]. For over 20 years, tissular edema identified both by traditional black blood imaging sequencing and more recently using T1 and T2 mapping, has also been described in Ch-CMP although its clinical application is still to be determined [161][162][163][164]. Nonetheless, an important limitation for CMR wide use of Ch-CMP evaluation is its availability in Latin America and the high costs it entails for healthcare systems when compared with TTE.…”
Section: Clinical Manifestations Diagnosis and Treatmentmentioning
confidence: 99%